Cyclosporin

Verify with FDA CVM →

53 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
53
Total Reports
7
Deaths Reported
1320.0%
Death Rate

Active Ingredients

Cyclosporin

Administration Routes

UnknownOralOphthalmicIntraocularAuricular (Otic)Topical

Species Affected

Dog 49
Cat 4

Most Affected Breeds

Shih Tzu 7
Chihuahua 3
Bulldog - French 3
Retriever - Labrador 3
Collie - Border 2
Retriever - Golden 2
Bulldog - American 2
Crossbred Canine/dog 2
Retriever - Chesapeake Bay 2
Domestic Longhair 2

Most Reported Reactions

Diarrhoea 9
Lethargy (see also Central nervous system depression in 'Neurological') 8
Vomiting 7
Decreased appetite 6
Polydipsia 5
Death by euthanasia 4
Not himself/herself 4
Urinary tract infection 4
Not eating 4
Immune mediated haemolytic anaemia 3
Polyuria 3
Lack of efficacy - NOS 3

Outcome Breakdown

Ongoing
19 (35.8%)
Outcome Unknown
16 (30.2%)
Recovered/Normal
10 (18.9%)
Died
4 (7.5%)
Euthanized
3 (5.7%)
Recovered with Sequela
1 (1.9%)

Data Summary

Metric Value
Total adverse event reports 53
Reports involving death 7
Case-fatality rate (reported events) 1320.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Cyclosporin Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 53 adverse event reports referencing Cyclosporin, including 7 reports in which the animal died — a 1320.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Cyclosporin. Reported administration routes include Unknown, Oral, Ophthalmic, Intraocular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Cyclosporin reports are Dog (49 reports), Cat (4 reports), with Dog accounting for the largest share. Within those species, Shih Tzu (7), Chihuahua (3), Bulldog - French (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Cyclosporin are Diarrhoea (9), Lethargy (see also Central nervous system depression in 'Neurological') (8), Vomiting (7), Decreased appetite (6). Of the 53 reports with a coded outcome, Ongoing is the leading category at 35.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Cyclosporin.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial